Co-Amoxiclav Aurobindo Pharma (Malta)

Co-Amoxiclav Aurobindo Pharma (Malta) combines amoxicillin and clavulanic acid for oral use. This antibiotic is designed to treat a range of bacterial infections by targeting resistant strains.

Co-Amoxiclav Aurobindo Pharma (Malta) is commonly used to treat bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. The combination of amoxicillin and clavulanic acid helps combat bacteria that may be resistant to amoxicillin alone. This medication is often prescribed for conditions where broad-spectrum antibiotic coverage is needed.

Common effects of Co-Amoxiclav Aurobindo Pharma (Malta) may include mild gastrointestinal discomfort, such as diarrhea or nausea. Some users might experience allergic reactions, though these are less frequent. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Handle Co-Amoxiclav Aurobindo Pharma (Malta) with care, especially if you have a history of allergies to penicillin or other antibiotics. Always follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. Store the medication in a cool, dry place away from direct sunlight.

Co-Amoxiclav Aurobindo Pharma (Malta) may interact with certain medications, including other antibiotics, blood thinners, and some antacids. Alcohol consumption should be avoided as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.